OXIGENE INC 4
4 · OXIGENE INC · Filed May 29, 2015
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-05-28+225,000→ 225,000 totalExercise: $1.43Exp: 2025-05-28→ Common Stock (225,000 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. 2015 Equity Incentive Plan, as partial compensation for his services as Chief Scientific Officer.
- [F2]25% of the Stock Options vest immediately, and the remainder will vest in 36 substantially equal monthly installments beginning on the one month anniversary of the grant date.